Claude's revenue just doubled in three months.
Anthropic's annualized run-rate revenue hit $65B by the end of July 2026, Bloomberg and TechCrunch reported. That's roughly 7x the $9B it was running at the end of 2025 — here's what the number means against OpenAI, and why profitability questions still linger ahead of the IPO.
+$18B in two and a
half months
Anthropic's annualized run-rate revenue reached $65B by the end of July 2026, Bloomberg reported on August 17, with TechCrunch and other outlets following. Counting from the $9B run-rate at the end of 2025, that's roughly a 7x jump in seven months.
The most recent stretch is even steeper: from $47B in May 2026 to $65B by end of July — a $18B gain in just two and a half months. On a quarterly basis it's more extreme still: preliminary Q2 (April-June) revenue topped $11.5B, more than 14x the same quarter a year earlier and more than double Q1's $4.73B, according to Bloomberg.
A run rate doesn't guarantee future revenue.
Still, this trajectory is shifting the industry's mood.
The timing, right before
an IPO, is the point
This isn't just a growth-rate story. Anthropic confidentially filed its S-1 on June 1, 2026, and this number lands as backing evidence for that filing's valuation.
Anthropic was valued at $965B in its May 29 Series H and confidentially filed its S-1 (IPO prospectus) on June 1, Fortune reported. This latest revenue surge is being read by the market as evidence that the valuation reflects real demand rather than hype alone. The run rate already climbed more than 5x from $9B at end-2025 to $47B by May 2026 — and then kept accelerating to $65B by end of July. The headline here isn't that growth continued; it's that the slope got steeper, not flatter.
The growth is being driven by enterprise demand and expanding coding/agent usage, according to Axios. Coding-focused products like Claude Code are moving beyond one-off chat usage and getting embedded directly into corporate development workflows — a pattern that lines up with the timing of this surge.
Ahead of OpenAI
toward the IPO line
| Anthropic (Claude) | OpenAI (GPT) |
|---|---|
| ~$65B annualized revenue (end of July) | ~$40B annualized revenue |
| S-1 confidentially filed 6/1 | Filing yet to be announced |
| IPO expected fall 2026 (first) | Expected to follow Anthropic |
Anthropic's latest annualized revenue has reportedly overtaken OpenAI's roughly $40B figure. Both companies are preparing confidential IPOs, and if things stay on track, Anthropic could go public ahead of OpenAI and DeepSeek as soon as this fall, Fortune reports.
Who this matters to,
and how
Enterprise buyers
The growth is corroborating evidence that Claude's enterprise adoption is real. Still, before signing multi-year contracts, it's worth checking actual earnings (Q3 results or the S-1 disclosure) for margins — not just the run rate.
Developers and engineers
If coding/agent usage really is driving the numbers, investment in developer-facing products like Claude Code is more likely to accelerate than slow down.
Individual users
Short-term pricing and features probably won't change much. But as the IPO approaches, there's room for profitability-driven price changes — worth watching for shifts in free or discounted tiers.
The questions that
don't go away
This isn't a purely bullish story. Fortune points out that justifying a $965B valuation would require Anthropic to eventually post Amazon-scale absolute profits, while in reality it has barely turned a profit so far. A run rate is just a single month's revenue multiplied by twelve — it says nothing about whether that pace holds. The weight of GPU procurement costs, and the possibility that growth gradually cools, are both risks that stay hard to see before the actual earnings are disclosed.
The next real test is the S-1's full disclosure, expected around the fall 2026 IPO. That's when GAAP-basis revenue, margins, and cash flow — not the run rate — finally become visible. Whether the numbers confirm this momentum or reveal a "fast-growing but thin-margin" business will shape both enterprise adoption decisions and investor valuations from that point on.